Dg. Schick et al., IN-VITRO ACTIVITY OF THE COMBINATION OF TROVAFLOXACIN AND OTHER ANTIBIOTICS AGAINST ENTEROCOCCI, Diagnostic microbiology and infectious disease, 29(4), 1997, pp. 233-239
The activities of trovafloxacin and ciprofloxacin against 38 strains o
f non-beta-lactamase-producing enterococci, resistant to ampicillin, 3
4 strains susceptible to ampicillin, and 3 vancomycin-resistant entero
cocci were studied. Tovafloxacin was move active than ciprofloxacin ag
ainst all the enterococci studied. The ampicillin-resistant strains we
re more susceptible than the ampicillin-susceptible strains to both ag
ents. The effect of combining trovafloxacin with gentamicin, ampicilli
n-sulbactam, novobiocin, rifampin, teicoplanin, and vancomycin was det
ermined for 17 strains by the checkerboard method. An additive effect
by inhibition was seen with all antibiotics studied. The results by ki
lling varied with the different agents studied. Gentamicin, ampicillin
-sulbactam, and novobiocin produced an additive killing effect with tr
ovafloxacin. Reduced killing was seen when rifampin, vancomycin, or te
icoplanin were added to trovafloxacin. (C) 1997 Elsevier Science Inc.